Faes Farma > Lines of Business > Global Out-Licensing

Global Out-Licensing

Descargar imagen: Global Outlicensing

Our R&D activities offer us innovative opportunities for out-licensing. We have wide ranging out-licensing agreements for our innovative products in more than 170 countries.

Allergy, venous insufficiency, irritable bowel syndrome, vitamin D deficiency and safer corticosteroids are just some of the areas we are dedicated to.

We have global multinational top-ranking companies as licensees and are sufficiently flexible to cater for both the most highly developed and demanding agencies and small companies in developing markets.

We look forward to collaborating with you.


Managing Director

Gonzalo López

+34 914 680 800

glopez@faes.es